Company intelligence / Profile preview

Cartesia Dx

Pittsburgh, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Cartesia Dx was a medical device company based in Pittsburgh, Pennsylvania, that specialized in developing thermal and 3D imaging systems for the diagnosis and management of rheumatoid arthritis. Founded in 2006 as Arthritis Imaging, Inc., the company's core technology was designed to provide objective, quantitative assessments of joint inflammation by measuring swelling and warmth. The company received early-stage funding from regional investors such as the Pittsburgh Life Sciences Greenhouse and Idea Foundry to advance its diagnostic platform. However, Cartesia Dx ceased operations and underwent bankruptcy liquidation in September 2008.

Therapeutic areas: Immunology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on Cartesia Dx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cartesia Dx.

Explore the full profile